DOBUTAMINE INJECTION USP
Google image searchProduct monograph
Active ingredient
dobutamine (dobutamine hydrochloride), 12.5 MG/ML
DIN: 02462729
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: HIKMA CANADA LIMITED
Date: 02-JUN-2022
ATC:
- C01 — CARDIAC THERAPY (ATC, ATC/DDD, )
- C01C — CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES (ATC, ATC/DDD)
- C01CA — Adrenergic and dopaminergic agents (ATC, ATC/DDD)
- C01CA07 — DOBUTAMINE (ATC/DDD)
Reference brand drug: Dobutrex
Pharmaceutical standard: USP
